Most bought healthcare stocks in Q3 2020
See which Healthcare stocks institutional investors increased the most in Q3 2020, measured as net growth in reported share positions from Q2 2020 into Q3 2020. Notable additions at the top of this list include BRISTOL-MYERS SQUIBB CO (BMY), MERCK & CO. INC. (MRK), PACIFIC BIOSCIENCES OF CALIF (PACB), ABBVIE INC (ABBV). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 18,840,701 | -$2.05M | 3 | 3 | 8 | 0 | 16 |
| MRK | MERCK & CO. INC. | 18,621,334 | $1.58M | 2 | 2 | 6 | 1 | 14 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 15,971,911 | $211.52K | 1 | 1 | 0 | 1 | 2 |
| ABBV | ABBVIE INC | 15,770,903 | $1.17M | 1 | 4 | 5 | 0 | 12 |
| AVTR | AVANTOR INC | 8,712,928 | $236.25K | 1 | 2 | 0 | 0 | 3 |
| EVH | EVOLENT HEALTH INC - A | 8,553,155 | $106.14K | 1 | 0 | 0 | 0 | 1 |
| CERS | CERUS CORP | 8,241,636 | $44.19K | 0 | 1 | 0 | 0 | 1 |
| PFE | PFIZER INC | 4,293,963 | $650.72K | 3 | 3 | 6 | 0 | 12 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 4,216,152 | $143.09K | 0 | 3 | 0 | 0 | 3 |
| UNH | UNITEDHEALTH GROUP INC | 3,814,863 | $1.54M | 3 | 4 | 10 | 2 | 18 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 3,668,035 | $143.92K | 0 | 1 | 0 | 0 | 1 |
| PMVP | PMV PHARMACEUTICALS INC | 2,641,840 | $93.78K | 1 | 0 | 0 | 0 | 1 |
| EDIT | EDITAS MEDICINE INC | 2,617,278 | $61.04K | 0 | 1 | 1 | 1 | 2 |
| TDOC | TELADOC HEALTH INC | 2,383,586 | $531.28K | 0 | 2 | 1 | 0 | 3 |
| CNC | CENTENE CORP | 2,184,731 | $37.15K | 2 | 2 | 0 | 0 | 4 |
| ATHA | ATHIRA PHARMA INC | 2,120,653 | $39.15K | 1 | 0 | 0 | 0 | 1 |
| VCYT | VERACYTE INC | 1,954,977 | $96.89K | 0 | 1 | 0 | 0 | 1 |
| GDRX | GOODRX HOLDINGS INC-CLASS A | 1,900,000 | $105.64K | 2 | 0 | 0 | 0 | 2 |
| ONVO | ORGANOVO HOLDINGS INC | 1,848,747 | $14.62K | 2 | 0 | 0 | 0 | 2 |
| TWST | TWIST BIOSCIENCE CORP | 1,516,988 | $165.65K | 0 | 1 | 0 | 0 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 1,366,938 | $211.35K | 2 | 0 | 4 | 1 | 6 |
| CLLS | CELLECTIS - ADR | 1,355,756 | $27.03K | 0 | 1 | 0 | 0 | 1 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,325,491 | $12.53K | 1 | 0 | 0 | 0 | 1 |
| PSNL | PERSONALIS INC | 1,238,258 | $44.83K | 1 | 1 | 0 | 0 | 2 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 1,223,449 | $21.18K | 1 | 1 | 1 | 0 | 3 |
| ELV | ELEVANCE HEALTH INC | 1,115,489 | $340.58K | 2 | 5 | 2 | 0 | 9 |
| ISRG | INTUITIVE SURGICAL INC | 981,986 | $727.61K | 3 | 1 | 1 | 0 | 5 |
| ACCD | ACCOLADE INC | 893,584 | $34.73K | 2 | 0 | 0 | 0 | 2 |
| EXAS | EXACT SCIENCES CORP | 850,762 | $137.00K | 2 | 1 | 1 | 0 | 4 |
| NVS | NOVARTIS AG-SPONSORED ADR | 818,503 | $51.42K | 1 | 2 | 4 | 0 | 8 |
| CDNA | CAREDX INC | 754,125 | $31.81K | 1 | 1 | 0 | 0 | 2 |
| BDX | BECTON DICKINSON AND CO | 717,824 | $96.25K | 1 | 3 | 5 | 0 | 11 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 717,516 | $4.18K | 0 | 1 | 0 | 0 | 1 |
| CORT | CORCEPT THERAPEUTICS INC | 686,000 | $17.16K | 0 | 1 | 0 | 0 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 664,700 | $25.55K | 0 | 1 | 0 | 0 | 1 |
| OMI | OWENS & MINOR INC | 649,050 | $58.40K | 0 | 1 | 0 | 0 | 1 |
| ILMN | ILLUMINA INC | 617,971 | $121.13K | 2 | 2 | 1 | 0 | 5 |
| ARCT | ARCTURUS THERAPEUTICS HOLDIN | 577,007 | $17.39K | 0 | 1 | 0 | 0 | 1 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 575,584 | $36.44K | 0 | 1 | 0 | 0 | 2 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | 525,900 | $18.55K | 0 | 2 | 1 | 0 | 3 |
| PODD | INSULET CORP | 507,941 | $140.95K | 2 | 0 | 1 | 0 | 3 |
| FATE | FATE THERAPEUTICS INC | 471,759 | $24.63K | 1 | 1 | 0 | 0 | 2 |
| PHR | PHREESIA INC | 470,654 | $15.36K | 0 | 1 | 1 | 0 | 2 |
| WAT | WATERS CORP | 465,663 | $153.02K | 0 | 2 | 1 | 0 | 3 |
| CAH | CARDINAL HEALTH INC | 445,641 | -$4.18K | 0 | 3 | 0 | 1 | 3 |
| EHC | ENCOMPASS HEALTH CORP | 439,765 | $37.69K | 0 | 2 | 1 | 0 | 3 |
| GH | GUARDANT HEALTH INC | 433,889 | $160.53K | 0 | 1 | 1 | 1 | 2 |
| SVRA | SAVARA INC | 389,700 | $425 | 1 | 0 | 0 | 0 | 1 |
| CDXS | CODEXIS INC | 379,931 | $4.81K | 0 | 1 | 0 | 1 | 1 |
| GMAB | GENMAB A/S -SP ADR | 358,245 | $18.11K | 0 | 1 | 2 | 0 | 3 |
Frequently asked questions about Most bought healthcare stocks in Q3 2020
What are the most bought Healthcare stocks in Q3 2020?
The most bought healthcare stocks in Q3 2020 are those with the largest increase in reported share counts across tracked institutional investors compared to Q2 2020, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q3 2020?
Among the managers we track, net additions were largest in companies such as BRISTOL-MYERS SQUIBB CO (BMY), MERCK & CO. INC. (MRK), PACIFIC BIOSCIENCES OF CALIF (PACB), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q2 2020).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.